Non‐neuronal cell responses differ between normal and Down syndrome developing brains
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Down syndrome (DS), the most common genetic cause of mental retardation, is characterized by reduced number of neurons and delayed myelination. Though non‐neuronal cells in the brain are vital for the development, survival, and function of neurons, there is a paucity of comparative studies of normal development and DS, in particular in the temporal lobe, a region of interest for cognitive decline. We evaluated immunoreactivity for CD68 (macrophage), HLA‐DR (microglia), Olig2 and TPPP/p25 (oligodendroglia), and GFAP (astroglia) in the germinal matrix (GM), temporal lobe white matter (TeWM) and hippocampus from 14 weeks of gestations to newborn in 28 DS patients and 30 age‐matched controls. The rate of increase of CD68 positive cells in the GM, CA1 hippocampal subregion and subiculum was significantly higher in DS. The density of Olig2 positive cells in the GM was lower in DS brains at early stages, then showed a transient increase contrasting controls. Olig2 expression increased more in the TeWM in DS, suggesting an altered pattern of oligodendrocyte progenitor generation. GFAP‐immunoreactivity in DS was significantly lower in the middle pregnancy period in the TeWM and did not increase between early and middle periods in the GM compared to controls, likely reflecting a defect in astrocyte production. The altered expression of non‐neuronal cell markers during normal development and DS may play a role in, or reflect, defective neurogenesis, leading to reduced number of neurons and delayed myelination in the developing DS brain. This has implications for the understanding of the mental retardation in DS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Glial Nature of Embryonic and Adult Neural Stem Cells
Kriegstein, A., & Alvarez-Buylla, A. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135600 · Cited by 2,475
Microglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
Sierra, A., Encinas, J. M., Deudero, J. J. P., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., Tsirka, S. E., & Maletic-Savatic, M. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.014 · Cited by 1,622 · cited 2×
“This may be associated with increased apoptosis and altered neurogenesis (Guidi et al., 2008; Rakic and Zecevic, 2000; Saijo and Glass, 2011; Sierra et al., 2010).”
BackgroundControl of Synapse Number by Glia
Ullian, E. M., Sapperstein, S. K., Christopherson, K. S., & Barres, B. A. (2001) · Science · doi:10.1126/science.291.5504.657 · Cited by 1,380
New roles for astrocytes: redefining the functional architecture of the brain.
Nedergaard, M., Ransom, B., & Goldman, S. A. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.008 · Cited by 1,334 · cited 3×
“Recent studies emphasized that non-neuronal cells, including macrophages, microglia, oligodendrocytes, and astrocytes, are involved in the healthy development of the central nervous system (CNS), and play an important role in various neurological diseases (Eroglu and Barres, 2010; Höftberger et al., 2010; Jakovcevski…”
BackgroundOccurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome
Wisniewski, K. E., Wisniewski, H. M., & Wen, G. Y. (1985) · Annals of Neurology · doi:10.1002/ana.410170310 · Cited by 1,159 · cited 1×
“Interestingly, DS patients suffer early AD in adult age (Wisniewski et al., 1985).”
BackgroundMicroglial cell origin and phenotypes in health and disease
Saijo, K., & Glass, C. K. (2011) · Nature Reviews Immunology · doi:10.1038/nri3086 · Cited by 1,100 · cited 4×
“Recent studies emphasized that non-neuronal cells, including macrophages, microglia, oligodendrocytes, and astrocytes, are involved in the healthy development of the central nervous system (CNS), and play an important role in various neurological diseases (Eroglu and Barres, 2010; Höftberger et al., 2010; Jakovcevski…”
BackgroundInfluentialThe bHLH Transcription Factors OLIG2 and OLIG1 Couple Neuronal and Glial Subtype Specification
Zhou, Q., & Anderson, D. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00677-3 · Cited by 1,059 · cited 3×
“Olig2 is an excellent marker for the specification and maturation of oligodendrocytes, which make myelin sheaths (Lu et al., 2002; Maire et al., 2010; Takebayashi et al., 2002; Yue et al., 2006; Zhou and Anderson, 2002).”
BackgroundThe Role of Microglia in the Healthy Brain: Figure 1.
Tremblay, M.-È., Stevens, B., Sierra, A., Wake, H., Bessis, A., & Nimmerjahn, A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4158-11.2011 · Cited by 992 · cited 2×
“Recent studies emphasized that non-neuronal cells, including macrophages, microglia, oligodendrocytes, and astrocytes, are involved in the healthy development of the central nervous system (CNS), and play an important role in various neurological diseases (Eroglu and Barres, 2010; Höftberger et al., 2010; Jakovcevski…”
BackgroundOrigin of oligodendrocytes in the subventricular zone of the adult brain
Menn, B., Garcia-Verdugo, J. M., Yaschine, C., Gonzalez-Perez, O., Rowitch, D., & Alvarez-Buylla, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1299-06.2006 · Cited by 972 · cited 2×
“Olig2 is expressed in postmitotic oligodendrocytes progenitors (Kitada and Rowitch, 2006; Ligon et al., 2006) and in some neural progenitor/stem cells in the subventricular zone (Hack et al., 2005; Ligon et al., 2006; Menn et al., 2006; Takebayashi et al., 2000).”
BackgroundRegulation of synaptic connectivity by glia.
Eroglu, C., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09612 · Cited by 813 · cited 2×
“…are involved in the healthy development of the central nervous system (CNS), and play an important role in various neurological diseases (Eroglu and Barres, 2010; Höftberger et al., 2010; Jakovcevski et al., 2009; Nedergaard et al., 2003; Saijo and Glass, 2011; Stefanits et al., 2012;…”
Background
Cited by
Human astrocytes in the diseased brain
Dossi, E., Vasile, F., & Rouach, N. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.02.001 · Cited by 250
Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling
Alpár, A., Tortoriello, G., Calvigioni, D., Niphakis, M. J., Milenkovic, I., Bakker, J., Cameron, G. A., Hanics, J., Morris, C. V., Fuzik, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms5421 · Cited by 96
New approaches to studying early brain development in Down syndrome
Baburamani, A. A., Patkee, P. A., Arichi, T., & Rutherford, M. A. (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14260 · Cited by 74
Quantitative MRI Analyses of Regional Brain Growth in Living Fetuses with Down Syndrome
Tarui, T., Im, K., Madan, N., Madankumar, R., Skotko, B. G., Schwartz, A., Sharr, C., Ralston, S. J., Kitano, R., Akiyama, S., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhz094 · Cited by 50
Regional Alterations in Cortical Sulcal Depth in Living Fetuses with Down Syndrome
Yun, H. J., Perez, J. D. R., Sosa, P., Valdés, J. A., Madan, N., Kitano, R., Akiyama, S., Skotko, B. G., Feldman, H. A., Bianchi, D. W., et al. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhaa255 · Cited by 33
“In fetopsy, altered development of neuronal cells in the temporal lobe was revealed (Golden and Hyman 1994; Kanaumi et al. 2013).”
InfluentialAberrant Oligodendrogenesis in Down Syndrome: Shift in Gliogenesis?
Reiche, L., Küry, P., & Göttle, P. (2019) · Cells · doi:10.3390/cells8121591 · Cited by 28
“Interestingly, several studies in DS indicated a neuro- to gliogenic shift, mainly focusing on the observed bias toward astrocytes [3,4,6,10].”
BackgroundComprehensive volumetric phenotyping of the neonatal brain in Down syndrome
Fukami-Gartner, A., Baburamani, A. A., Dimitrova, R., Patkee, P. A., Ojinaga-Alfageme, O., Bonthrone, A. F., Cromb, D., Uus, A. U., Counsell, S. J., Hajnal, J. V., et al. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad171 · Cited by 24
Rethinking intellectual disability from neuro- to astro-pathology.
Fernández-Blanco, Á., & Dierssen, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239039 · Cited by 19
“Nevertheless, there are some discrepancies that suggest that GFAP is reduced in particular brain areas [114,115].”
BackgroundIshihara, K. (2021) · Genes · doi:10.3390/genes12101598 · Cited by 8
“Furthermore, fewer neurons and more astrocytes are found in the prenatal brain with DS, suggesting that the neural progenitor cells (NPCs) in DS show a greater shift towards glial lineages: differentiating into astrocytes, preferentially [4,13,14].”
Background
Metadata
- Authors
- Kanaumi, T., Milenkovic, I., Adle‐Biassette, H., Aronica, E., & Kovacs, G. G.
- Venue
- International Journal of Developmental Neuroscience
- Publisher
- Wiley
- Published
- 2013-10-07
- Volume
- 31
- Issue
- 8
- Pages
- 796-803
- ISSN
- 0736-5748 (ISSN-L)
- 1873-474X
- OpenAlex
- W2062991065
- Cited by
- 38
- References
- 21
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.